Steven Cohen’s Guardant Health GH Stock Holding History

Steven Cohen’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.88M	Sell	32,500 -12,300	-27%	-$1.34M	0.01%	1780
2026 Q1	$4.14M	Buy	+44,800	New	+$4.5M	0.01%	1829
2024 Q2	–	Sell	-300,000	Closed	-$6.19M	–	2070
2024 Q1	$6.19M	Buy	+300,000	New	+$6.43M	0.02%	899
2023 Q1	–	Sell	-7,500	Closed	-$204K	–	2352
2022 Q4	$204K	Buy	+7,500	New	+$343K	﹤0.01%	1260

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Steven Cohen's GH Position: Q2 2026 in Review

Steven Cohen increased its Guardant Health (GH) stake by 32% in Q2 2026, buying an estimated $24.5M and bringing the position to 920,807 shares worth $138M. The position accounts for 0.15% of the portfolio, ranked #134.

Steven Cohen first reported a position in GH in Q1 2019 and has held it in 20 quarters since. The position peaked at $153M in Q4 2025. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Steven Cohen held 920,807 shares of Guardant Health worth $138M as of Q2 2026.
Steven Cohen bought 224,867 Guardant Health shares in Q2 2026, an estimated $24.5M.
Guardant Health made up 0.15% of Steven Cohen's portfolio in Q2 2026, its #134 holding.
Steven Cohen first reported a position in Guardant Health in Q1 2019 and has held it in 20 quarters since.
Steven Cohen's Guardant Health position peaked at $153M in Q4 2025.
595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.